Trial Profile
Pilot Study of Bumetanide for Newborn Seizures: A Phase I Study of Pharmacokinetics and Safety of Bumetanide for Neonatal Seizures
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Dec 2020
Price :
$35
*
At a glance
- Drugs Bumetanide (Primary) ; Phenobarbital
- Indications Neonatal seizures
- Focus Adverse reactions; Pharmacokinetics
- 02 Jan 2019 Status changed from active, no longer recruiting to completed.
- 10 Apr 2018 Planned End Date changed from 1 Aug 2018 to 1 Dec 2018.
- 10 Oct 2017 Planned End Date changed from 1 Dec 2017 to 1 Aug 2018.